We describe a new gas-chromatographic/mass-spectrometnc (GC/MS) isotope-dilution method for determination of serum cholesterol. The method has been fully optimized and documented to provide the high accuracy and precision expected for a Definitive Method. In the presence of [ 
multiple-ion detection. The gas chromatograph was equipped with a 25 m x 0.31 mm (i.d.) column made of fused-silica with 0.52-pm-thick film of cross-linked methyl silicone ("Ultra-i," from Hewlett-Packard, Palo Alto, CA 94304). The column inlet was inserted into the iiijector about 10 mm above the bottom glass insert tube and the outlet was led directly through the GCIMS transfer line just to the entrance of the ion volume of the ion source. New cohunns were conditioned under a helium pressure of 69 kPa by increasing the temperature from 50 to 300#{176}C at 5 #{176}C/min and holding at 300#{176}C for 3 h before introducing the column outlet into the GCIMS transfer line. The mass spectrometer was calibrated at 45 eV with FC-43 (perfluorotributylamine)
supplied by Finnigan MAT. The GC/MS temperature settings were as follows: injector, oven, separator oven, and transfer line, 295 #{176}C; ionizer, 140 #{176}C; and manifold, 80#{176}C. The helium head pressure was maintained at 69 kPa. The injector was used in the split mode at 30 mL/min; the sweep was set at 10 mL/min and the column flow at 0.8 mL/min (linear velocity = 19 cm/a). The preamplifier sensitivity was set at i0; electron energy was in the range of 35 to 50 eV, optimized for maximal response; emission current was at 0.25 mA; and the electron multiplier was used in the range of 1000 to 1900 V, as required to maintain sufficient sensitivity. Acquisitions of ions at mlz 368.5 (±0.5) and at miz 370.5 (±0.5) were done successively for 0.105 s at each mlz during scan cycles of 0.22 s.
Pipetting apparatus.
We used a Model 25000 automatic pipette (Micromedic Systems, Inc., Huntsville, AL), equipped with a foot-switch, a 10O-L sampling piston (0.25 mm i.d. Teflon delivery tip), and a 1-mL piston to sample aliquots of serum and standards and dispense them with an ethanolic KOH solution containing the labeled internal standard. Hexane and water were dispensed with a Digital Dilutor/Dispenser (Hamilton Co., Reno, NV) equipped with a foot switch, a dispenser valve block, and 1-and 2.5-mL syringes, 2.2 mm (i.d.) Teflon ifil tubings, and 0.085 mm (i.d.) Teflon nontapered dispensing probes. We used 100O-L Micro-Macropipette (Centaur Sciences Inc., Stanford, CA) with disposable tips to remove aliquots of hexane extracts.
Mixing apparatus. The Thermolyne
Maxi-Max (Allied! Fisher Scientific, Fair Lawn, NJ) we used was equipped with a foam-rubber top. It was capable of vortex-mixing several tubes at once at an intensity controlled by the pressure applied.
Glassware. All volumetric glassware was Class A. For hydrolysis and extraction we used 13 x 100 mm Pyrex culture tubes with Teflon-faced rubber-lined screw caps. For derivatization procedures we used 1.5-mL screw-top disposable vials with Teflon-faced septum caps (Varian, Palo Alto, CA). Except for the 1.5-mL vials we soaked all glassware, clean and dry, in chloroform/methanol (2/1 by vol) for 5 to 30 mm, rinsed twice with distilled water, soaked in dilute (50 mLIL) hydrochloric acid for 15 mm, and rinsed several times with distilled water.
Reagents n-Hexane:
Certified 99 mol % pure (from Fisher Scientific).
Water: In preparing the reagents or reconstituting sera, we used distilled water, first demineralized by passage through a high-efficiency demineralized column (Barnstead Blue 00803; Fisher Scientific). To ensure that the water was sterile and C02-free, we boiled it for 30 miii, allowing it to cool after covering it with glass wool.
Cleaning 
Cholesterol standard solutions:
Prepare two bracketing cholesterol standards on the same day as the primary solution at concentrations of 90-97% and 103-110%, respectively, of the cholesterol content of each serum, as determined in a preliminary run. Because these solutions are prepared by weight, measure the density of ethanol (DE), using a 200-mL volumetric flask to do so. Prepare solutions of the desired concentrations (Cs) directly in preweighed 125-mL Nalgene bottles weighed to ± iO g (W1) by first adding the required volume of primary cholesterol solution (V1) according to the following scheme: 
Add the Ve from a 100-mL buret and reweigh the bottle (W3). Calculate the actual concentration (CS) as follows: 
CmL=(lOxRmLxM)-RmL

Other chemicals:
We used N,O-bis(trimethylsilyl)acetamide (Pierce Chemical Co., Rockford, IL) for silylation and glass-distilled 2,2,4-trimethylpentane (Caledon Laboratories Ltd.) for cleaning injection syringes. Sterols other than cholesterol were supplied by Steraloids Inc., Wilton, NH.
Procedures
Measurements
of peak area ratio of primary solution of [3,4-'3C] Each vial was weighed to the nearest 10 g (W,). The volume of water prescribed by the manufacturer was delivered against the internal wall of the vial while the vial was being continually rotated. We were quite careful to avoid wetting the neck of the vial or touching the serum particles with the pipet. We weighed the stoppered vials again (Wy).
We briefly mixed the contents of each vial at six 10-mm intervals, the first three by gently swirling and the last three by gently inverting the vials three times. Each solution was assayed within 4 h when kept at room temperature or within 8 h if refrigerated. After use, the vials with their individual stoppers were cleaned. The stoppers were dried with a piece of disposable tissue. The vials were rinsed twice with ethanol and twice with acetone, and the last traces of acetone were removed with a stream of nitrogen. We then weighed each vial with its stopper (Wi). The weight of dry serum (GD) and the volume of water added (Va) were calculated as follows:
of water at room temperature.
Protocol for diluting serum and cholesterol standards with [3, diluting solution: To decide what volumes of samples, bracketing standards, and diluting solutions to use, we made preliminary measurements on the basis of the manufacturers' declared values.
Because dilutions of samples and standards with the labeled cholesterol solution were considered the greatest source of variation, dilutions were made continuously without interruption.
The dilutions of one type of serum and its bracketing standards were prepared and given numbers in the following sequence: 1-6 (low standard), 7-10 (serum sample 1), 11-13 (serum sample 2), and 14-18 (high standard).
For sera with an expected cholesterol concentration (EC) <2.00 g/L, aliquots of serum and its bracketing standards (VS) were set at 100 j.L and diluted with a volume, in microliters, of diluting solution (VD) adjusted according to the EC: VD = (EC/2.00) x 1000 tL If VD was less than 800 1zL, a volume of ethanolic KOHJTriton X-100 solution was first added to the recipient screwcapped tubes to bring the final total volume to about 1000 L.
For sera with EC >2.00 g/L, we set VD at 1000 p.L and adjusted VS in iL according to EC:
The diluent container of the Micromedic System automatic pipette is shaped such that at least 1 cm of diluent remains at the bottom after the last dilution. We primed the automatic pipette with the diluent solution (up to 20 mL). The serum in the vials was mixed very gently by rolling and tilting the vials before dilution. If a vial consistently showed foaming, about 1-2 mL of the lower portion was transferred with a Pasteur pipette into a 12 x 75 mm test tube. The delivery tip of the pipette was then immersed about 5 mm into the sample, in an area free of air bubbles. Immediately after filling the pipette, we withdrew the tip, sliding it gently along the wall of the vial; then wiped the tip towards its end with a disposable tissue. We dispensed the standards or samples aliquots and diluent into 13 x 100 mm screwcapped tubes, placing the tip in the center of the tube about 1 cm above the expected final level of liquid. Again, we withdrew the tip by moving it to touch the wall of the tube, sliding it gently and wiping it as described above. We capped the tubes but did not mix their contents in any way until the second half of hydrolysis.
After all dilutions for one experiment were completed, we cleaned the pump tubings and syringes by pumping 25 mL of 70% ethanol, followed by 25 mL of absolute ethanol. To dry the tubings, pistons, and chambers, we first pumped air to empty them, then dismantled the apparatus, wiping the pistons and blowing air through the tube and chambers.
Hydrolysis: The capped tubes were incubated for 30 mm, without mixing, in a water bath at 70#{176}C. We then mixed the tubes' contents by lightly and briefly pressing five times on the foam rubber top of the Maxi-Mix, then continued the incubation for another 30 mm.
Extraction: After the tubes had cooled to room temperature, we added 2 mL of hexane from a 2.5-mL syringe, using the Hamilton Digital Dilutor, then tightly capped the tubes again. We mixed the tubes' contents by pressing briefly and repeatedly 10 times on the top of the Maxi-Mix, then shaking each tube vigorously by hand for 1 mm. Next we added 1 mL of water from a 1-mL syringe with the Hamilton Digital Dilutor. Again the tubes were capped, their contents mixed as described above and allowed to stand for 5 mm.
The tubes' contents were mixed a third time as described above. After 15 mm, we transferred 1 mL of the hexane layer with a 1-mL Centaur pipette (disposable tip) to a 1.5-mL autosampler vial (Varian). If it was not practical to evaporate the hexane at this time, we stored the vials overnight under reduced pressure at 4 #{176}C.
Hexane evaporation: We evaporated the hexane under a gentle flow of nitrogen, then capped each vial immediately, to minimize exposure to air. The vials were stored in the dark under reduced pressure at 4 #{176}C until silylation.
Silylation: Before proceeding with silylation for quantitative analysis, we derivatized specific samples (i.e., vial no. 1, 7, or 14) to ascertain the GC/MS sensitivity. Batches of samples to be run twice by GC/MS within 8 h were silylated in the following order: aliquots A, comprising vials from dilution no. 4 (low standard), 9 (sample 1), 16 (high standard), 12 (sample 2), and 4 (low standard); and aliquots B, comprising vials no. 17 (high standard), 10 (sample 1), 6 (low standard), 13 (sample 2), and 18 (high standard). We added N,O-bis(trimethylsilyl)acetamide through the septa of the vials, using a 500-4
Hamilton gas-tight syringe. The volume was based on the serum cholesterol concentration: 0.15 mL for 1.00-1.30 giL, 0.2 mL for 1.30-1.60 g/L, and 0.3 mL for >1.90 g/L. After 10, 20, and 30 mm, we rolled each vial on its side to ensure complete silylation of any cholesterol that might have adhered to the side of the vial. In case of delay in analysis the vials were kept overnight at 4#{176}C.
OCIMS measuring conditions:
Because A helium pressure of 69 kPa was selected because it gave an optimal peak-area response, with full resolution of cholesterol and cholestanol. Use of a pressure of 104 kPA gave incomplete resolution of these sterols.
An injection split volume of 10 mL of helium per minute gave incomplete resolution of cholesterol and cholestanol, while split volumes of 20 to 50 mL gave full resolution of these sterols with decreasing peak-area responses corresponding to smaller amounts of cholesterol applied to the column.
Isothermal column temperatures
from 285 #{176}C to 305 #{176}C (in increments of 5 #{176}C) did not affect resolution but gave small increases in peak-area responses while the retention times decreased from 11 to 6.5 mm. We selected a column temperature of 295 #{176}C, to give a short retention time and to avoid the heat stress imposed on columns and fittings by higher temperatures.
The injector temperature was set at 295 #{176}C, to minimize septum deterioration, because higher temperatures (tested up to 315 #{176}C) offered no advantages of resolution, retention times, or peak-area responses.
Under the above optimized conditions and terminating the peaks when the scan height was 2% of the maximal scan height, for greater precision (5), the cholesterol peaks gave about 20 scans at half height and about 50 scans at the base, which well exceeds the minimum required to adequately define the peak and to ensure high precision (10, 11). injected 1-4 samples with a 10-4 Hamilton syringe according to the silylation order described above in which each serum was bracketed with two standards. After each injection we rinsed each syringe with trimethylpentane and dried it. After completing the series for aliquots A, injections were repeated in reverse order. The series for aliquots B was then done in the same way as A. We measured areas at m/z 368.5 and 370.5 for each chromatogram, utilizing the cross-hairs and viewing the baseline amplified in the log scale. The baseline was based on approximately 50 scans on the left (ascending) side of the peak. The final scan of the peak was set as the first scan to the right of the peak having a height of <2% of the maximal peak height. As a rule, the three injections for a sample and its two bracketing standards were rejected and repeated if the area at mlz 370.5 of [3,4-13Cjcholesterol for any one of the three was less than half that of any one of the other two areas at m/z 370.5.
Linearity of peak
Concentration determination:
The where Va is the actual volume of water added for reconstitution and V0 is the exact specified volume. The correction factor Va/Ve was derived from the more exact factor (Va + Vd)/(Ve + Vd), where V, the volume occupied by dry serum, contributed only a negligible difference.
Finally we also corrected not only for the volume of water of reconstitution but also for any variation in the mass (g) of lyophilized serum from vial to vial.
Validation of measurements within a serum vial: In rare cases, the ranges of concentrations for two series of injections of one aliquot exceeded 1%. In such cases, after verifying the areas and calculations, we carried out two more series of injections and used the latter if they checked within 1%. If they did not check, we performed a third series and used the mean of the three sets. In rare caseswhere the CV of the four measurements from two aliquots of one serum sample exceeded 0.5%, we completed two runs of injections of an extra aliquot and bracketing standards and used the new values with those from one of the two other aliquots in closer agreement. If the CV was still >0.5%, all values were discarded because of imprecision between aliquota.
Results and Discussion
Treatment of serum with ethanolic KOH:
The hydrolytic conditions were developed in a separate study, with cholestane as internal standard and use of a Hewlett-Packard 5830 gas chromatograph. (Table 1) , and completely hydrolyze cholesteryl ester standards (Table 2) . No significant differences were obtained in the cholesterol concentrations of a serum sample (7.91 mmol/L) and the area ratios (cholesterollcholestane) of a cholesterol standard (7.76 mmol/L) following saponification for 5, 10, 20, 40, and 60 mm. The hydrolysis procedure of the proposed method was further refined by incorporating Triton X-100 in the ethanolic KOH solution (9) , not only to aid in disrupting serum lipoprotein complexes but also effectively to minimize protein precipitation during mixing. Essentially the same results were obtained whether or not Triton X-100 was present. However, we used Triton X-100 because it rendered the hydrolysis step less critical, prevented protein precipitation in the automatic pipettor probe during sampling, and eliminated troublesome air bubbles within the tubings of the pipettor.
With hydrolytic conditions as
Resolution of cholesterol and other sterols: Figure 1 For each of seven reconstituted lyophilized sera, 32 cholesterol measurements were obtained from a sample of eight vials, two vials being analyzed on any given day. From each vial, two aliquots were taken, duplicate determinations being performed on each aliquot. We usually analyzed eight vials of a serum over a period of six weeks, except for serum 5, in which this interval was extended to three months. The weight of lyophilized serum was also measured from the difference in weight of the vial before reconstitution and after being emptied, cleaned, and dried.
We analyzed the data for each serum by a nested analysisof-variance (A1'ovA) procedure (13), usinga statistical analysis system (14). Table 4 summarizes the serum dry-weight measurements. In general, the overall variation between vials ranged from 0.2% to 0.44%, with the greatest source of variation within days.While the variation in the serum dryweights may be regarded as a source of variation in the cholesterol content of each vial, the intrinsic cholesterol content may not be proportional to the serum dry-weight, because the differences in weights may also be due to lack of uniformity in the moisture content of lyophilized serum and (or) the technique of weighing (e.g., additional moisture due to handling of the serum vials). Table 5 Table 6 summarizes the results for the seven serum pools. Occasionally, for some sera, the estimated variance of a component was negative, in which case the variance of that component was equated to zero and the remaining components were recalculated. The variance of those components estimated to be negative are listed as zero. The concentration values have been expressed in three ways, explained previously under Concentration determination.
As shown by the mean values in Table 6 , the final concentration values in mmol/Le units were very slightly lower than in mmol/L units in two cases. This difference indicated a slight shortage in the volume of water added for reconstitution in these cases, owing to human errors or to traces of water adhering inside the pipette. Usually this correction decreased the overall CV only slightly, but in the case of serum 3 the overall decrease in CV was considerable. Because greater confidence is given to the measurement of the water added by weight than by the actual pipette volume, the reporting of cholesterol in mmol/Le units is considered more accurate. Expressing the cholesterol values in mmol/Le units per gram of dry serum (Table 6 ) somewhat improved the total CV for samples 3 and 7 by decreasing the among-vial variation. The improvement is probably related to variation in the dry-weight content of the vials. Some sera (no. 2,4, and 6), showed practically no among-vial variation, while others (sera no. 1, 3, and 7) showed statistically significant differences among vials (P <0.05), which indicated lack of homogeneity of the material among vials. In general, the results of the study (expressed in units of mmol/Le or mmollLe per gram) demonstrate that the present method meets the criterion of CV <0.5%, which has been advocated for Definitive Methods (5).
Accuracy of serum cholesterol measurements: Imprecision can obviouslyaffect accuracy, but high precision does not guarantee accuracy, which must be further demonstrated by eliminatingsourcesofinaccuracy.
Inaccuracy may arise from incompletehydrolysis (4), from incomplete liberation of cholesterol in lipoproteins, and from the instability or decomposition of cholesterol and labeled internal standard (4). Cohen 8Total CV basedon overall standard deviation ofsingle measurement SD overall = V52 within-aliquot + 52among-aliquot + 52among-vial #{247} 52among-day.
cdt: among-day = 3; among-vial = 2; among-aliquot = 6; wlthin-aliquot = 12; total = 23. The value of 3.72 mmolJL we obtained for serum 5 (Table  6) In conclusion, the accuracy of serum measurements by the proposed method isbased on the elimination of sources ofinaccuracythat may arise from hydrolysis, from instabilityand decompositionof cholesterol and labeledinternal standard, and from interfering sterols that may be present in serum. Measurements of a referenceserum by the proposedmethod gave values in agreement with the NBS method (5).
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